Latest News
December 03, 2021
Not intended for U.S. and UK Media
Phase III trial with Nubeqa™ (darolutamide) in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer
November 15, 2021
Not intended for U.S. and UK Media
Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease
November 11, 2021
Not intended for U.S. and UK Media
New Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fraction
Our Stories
Please enter a term to search